Page last updated: 2024-09-03

b 4162 and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

b 4162 has been researched along with 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole in 1 studies

Compound Research Comparison

Studies
(b 4162)
Trials
(b 4162)
Recent Studies (post-2010)
(b 4162)
Studies
(1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole)
Trials
(1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole)
Recent Studies (post-2010) (1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole)
50102900104

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andoh, T; Kuraishi, Y1

Other Studies

1 other study(ies) available for b 4162 and 1,3-dihydroxy-4,4,5,5-tetramethyl-2-(4-carboxyphenyl)tetrahydroimidazole

ArticleYear
Quantitative determination of endogenous nitric oxide in the mouse skin in vivo by microdialysis.
    European journal of pharmacology, 1997, Aug-13, Volume: 332, Issue:3

    Topics: Animals; Benzoates; Bradykinin; Bradykinin Receptor Antagonists; Enzyme Inhibitors; Imidazoles; Male; Mice; Mice, Inbred ICR; Microdialysis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Receptor, Bradykinin B2; Skin

1997